X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs TEVA PHARMA (Israel) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   TEVA PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
TEVA PHARMA
Dec-13
STERLING BIOTECH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs113,014-   
Low Rs32,618-   
Sales per share (Unadj.) Rs26.81,729.8-  
Earnings per share (Unadj.) Rs-15.0108.1-  
Cash flow per share (Unadj.) Rs-5.5247.9-  
Dividends per share (Unadj.) Rs094.60-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs54.91,921.5-  
Shares outstanding (eoy) m267.87848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 15.9%   
Avg P/E ratio x-0.526.1 -1.8%  
P/CF ratio (eoy) x-1.311.4 -11.2%  
Price / Book Value ratio x0.11.5 8.6%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,8622,388,129 0.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.332,637.1 16.2%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.02,038.8 -145.1%   
INCOME DATA
Net Sales Rs m7,1811,466,874 0.5%  
Other income Rs m430-   
Total revenues Rs m7,2231,466,874 0.5%   
Gross profit Rs m947401,704 0.2%  
Depreciation Rs m2,543118,569 2.1%   
Interest Rs m4,37728,812 15.2%   
Profit before tax Rs m-5,931254,324 -2.3%   
Minority Interest Rs m01,155 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-166,950 0.0%   
Tax Rs m-1,924-3,105 62.0%   
Profit after tax Rs m-4,00791,634 -4.4%  
Gross profit margin %13.227.4 48.2%  
Effective tax rate %32.4-1.2 -2,657.5%   
Net profit margin %-55.86.2 -893.2%  
BALANCE SHEET DATA
Current assets Rs m14,335990,721 1.4%   
Current liabilities Rs m49,809863,993 5.8%   
Net working cap to sales %-494.08.6 -5,718.3%  
Current ratio x0.31.1 25.1%  
Inventory Days Days40391 444.3%  
Debtors Days Days17196 177.9%  
Net fixed assets Rs m55,432479,113 11.6%   
Share capital Rs m2683,611 7.4%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7011,629,419 0.9%   
Long term debt Rs m9,478750,045 1.3%   
Total assets Rs m73,9883,352,277 2.2%  
Interest coverage x-0.49.8 -3.6%   
Debt to equity ratio x0.60.5 140.1%  
Sales to assets ratio x0.10.4 22.2%   
Return on assets %0.53.6 13.9%  
Return on equity %-27.35.6 -484.6%  
Return on capital %-6.44.9 -130.3%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719233,744 0.7%  
From Investments Rs m-3,148-82,825 3.8%  
From Financial Activity Rs m1,426-280,391 -0.5%  
Net Cashflow Rs m-3-129,473 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 72.21 Rs / USD

Compare STERLING BIOTECH With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare STERLING BIOTECH With: TORRENT PHARMA  PANACEA BIOTECH  J.B.CHEMICALS  DR. REDDYS LAB  WYETH LTD  



Today's Market

Indian Indices Trade in Red, Oil on the Boil, and Top Stocks in Action(Pre-Open)

The BSE Sensex closed lower by 53 points to end the day at 36,305. While the broader NSE Nifty ended the day down by 136 points to end at 10,975.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Sep 24, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS